Ultragenyx Pharmaceutical (RARE) Tax Rate Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.00 |
| Dec 31, 2025 | -100.00 |
| Sep 30, 2025 | -26.00 |
| Jun 30, 2025 | -17.00 |
| Mar 31, 2025 | -40.00 |
| Dec 31, 2024 | -272.00 |
| Sep 30, 2024 | 18.00 |
| Jun 30, 2024 | -20.00 |
| Mar 31, 2024 | 4.00 |
| Dec 31, 2023 | 317.00 |
| Sep 30, 2023 | 222.00 |
| Jun 30, 2023 | -27.00 |
| Mar 31, 2023 | 6.00 |
| Dec 31, 2022 | -11.00 |
| Sep 30, 2022 | -238.00 |
| Jun 30, 2022 | 19.00 |
| Mar 31, 2022 | -9.00 |
| Dec 31, 2021 | 28.00 |
| Sep 30, 2021 | 21.00 |
| Jun 30, 2021 | -199.00 |
| Mar 31, 2021 | 7.00 |
| Dec 31, 2020 | 251.00 |
| Sep 30, 2020 | -20.00 |
| Jun 30, 2020 | 183.00 |
| Mar 31, 2020 | -12.00 |
| Dec 31, 2019 | -266.00 |
| Sep 30, 2019 | 2.00 |
| Jun 30, 2019 | -2.00 |
| Mar 31, 2019 | -35.00 |
| Dec 31, 2018 | -11.00 |
| Sep 30, 2018 | -28.00 |
| Jun 30, 2018 | -17.00 |